Payne Joseph E 4
4 · Arcturus Therapeutics Holdings Inc. · Filed Nov 28, 2022
Insider Transaction Report
Form 4
Payne Joseph E
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2022-11-23$16.51/sh+5,000$82,550→ 1,480,097 total
Footnotes (1)
- [F1]Represents the purchase price paid by the Reporting Person for the shares of common stock, $0.001 par value per share, of the Registrant, in an open market transaction.